DOCSLIB.ORG

Medyczna Wokanda

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Medyczna Wokanda ISSN 2081-4143 POZNAÑ 2011 NR 3 § MEDYCZNA WOKANDA „MEDYCZNA WOKANDA” / „MEDICAL DOCKET” „Medyczna Wokanda” ukazuje siê pod patronatem honorowym Polskiego Towarzystwa Prawa Medycznego „Medical Docket” is published under the honorary auspices of Polish Association of Medical Law RADA PROGRAMOWA / ADVISORY COMMITTEE: prof. JUDr Jan Filip (Uniwersytet Masaryka, Brno, Czechy), prof. zw. dr hab. n. prawn. Marian Filar (Uniwersytet im. Miko³aja Kopernika, Toruñ), dr n. prawn. Attina Krajewska (School of Law College of Social Science and International Relations University of Exeter), prof. dr hab. n. med. Romuald Krajewski (Przewodnicz¹cy – Naczelna Izba Lekarska, Warszawa), prof. JUDr Stanislav Mrâz (Uniwersytet Mateja Bela Bañska Bystrzyca, S³owacja), prof. C. J. J. Mulder, MD PhD (Department of Gastrocenterology and Hepatology VU Univerity Medical Centry, Amserdam), dr n. med. Jolanta Or³owska-Heitzman (Uniwersytet Jagielloñski, Naczelna Izba Lekarska), prof. n. prawn. Julio César Ortiz-Gutierrez (Universidad Externado de Colombia), prof. dr hab. n. prawn Lech Paprzycki (Prezes Izby Karnej S¹du Najwy¿szego, Akademia im. Leona KoŸmiñskiego, Warszawa), prof. dr n. prawn Thomas Schomerus (Leuphana Universitat Lueneburg), prof. dr n. prawn. À.Ñëèíüêî (Woroneski Uniwersytet Pañstwowy), prof. zw. dr hab. n. prawn. Eleonora Zieliñska (Uniwersytet Warszawski) REDAKCJA / EDITORIAL BOARD: REDAKTOR NACZELNY / EDITOR-IN-CHIEF prof. zw. dr hab. Krzysztof Linke (Uniwersytet Medyczny im. K. Marcinkowskiego, Poznañ) ZASTÊPCA REDAKTORA NACZELNEGO / DEPUTY EDITOR-IN-CHIEF prof. zw. dr hab. Jacek Sobczak (Sêdzia S¹du Najwy¿szego, Prodziekan Wydzia³u Prawa Szko³y Wy¿szej Psychologii Spo³ecznej, Warszawa) SEKRETARZ REDAKCJI / ASSISTANT EDITOR dr hab. Jêdrzej Skrzypczak (Uniwersytet im. Adama Mickiewicza, Poznañ, Wielkopolska Izba Lekarska) ZASTÊPCA SEKRETARZ REDAKCJI / DEPUTY ASSISTANT EDITOR dr Bartosz Hordecki (Uniwersytet im. Adama Mickiewicza, Poznañ) REDAKTORZY TEMATYCZNI/ THEMATIC EDITORS: dr n. prawn. Joanna Haberko (prawo medyczne), dr Bartosz Hordecki (filozofia, etyka i deontologia zawodowa), dr n. med. Krzysztof Kordel (medyczne samorz¹dy zawodowe, odpowiedzialnoœæ zawodowa lekarzy, medycyna s¹dowa), dr Tomasz Maksymiuk (zdrowie publiczne), lek. Grzegorz Wrona (system ochrony zdrowia) REDAKTOR STATYSTYCZNY / STATISTIC EDITOR: dr Agnieszka Wiesio³owska (Uniwersytet Medyczny, Poznañ), REDAKTOR JÊZYKOWY /LINGUISTIC EDITOR: mgr Anna Hordecka (jêzyk polski, absolwentka Instytutu Filologii Polskiej Uniwersytetu im. Adama Mickiewicza w Poznaniu) Adres redakcji / Editorial Office: Okrêgowy S¹d Lekarski Wielkopolskiej Izby Lekarskiej w Poznaniu, ul. Nowowiejskiego 51, 61-734 Poznañ, tel. +48 783 993 413, tel./fax 61 855 45 11 adres mailowy: [email protected], adres strony internetowej: http://www.wil.org.pl/ Czasopismo recenzowane zgodnie z wytycznymi Ministerstwa Nauki i Szkolnictwa Wy¿szego. This scientific journal is peer-reviewed in accordance with Ministry of Science and Higher Education guidelines Redakcja nie zwraca materia³ów niezamówionych oraz zastrzega sobie prawo skracania i adiustacji tekstów. The Editorial Office does not return unsolicited material and reserves the privilege to adjust the format of the article. WYDAWCA / PUBLISHER: Naczelna Izba Lekarska, ul. Sobieskiego 110, 00-764 Warszawa, tel. 22 559 13 00 ISSN 2081-4143 Prenumeratê instytucjonaln¹ mo¿na zamawiaæ w oddzia³ach firmy Kolporter S.A. na terenie ca³ego kraju. Informacje pod numerem infolinii 0801-205-555 lub na stronie internetowej http://dp.kolporter.com.pl/ Nak³ad 600 egz., cena netto 25,00 z³, cena brutto 26,25 z³ Sk³ad komputerowy – „MRS”, 60-408 Poznañ, ul. P. Zo³otowa 23, tel. 61 843 09 39 Druk i oprawa – UNI-DRUK sp.j., 62-030 Luboñ, ul. Przemys³owa 13, tel. 61 899 49 49 do 52 Spis treœci Od Redakcji ........................... 7 Marek WONIAK, Wielkopolska sojusznikiem transplantacji ........... 9 ARTYKU£Y I STUDIA Wojciech DYSZKIEWICZ, Transplantacja p³uc ............... 11 Ewa SPEICHERT-M¥DRA, Krzysztof OLBROMSKI, Pozyskiwanie komórek krwiotwórczych w teorii i praktyce .................. 17 Jacek WACHOWIAK, Transplantacje komórek krwiotwórczych od dawców niespokrewnionych u dzieci i m³odzie¿y ................ 25 Marek JEMIELITY, Powstanie programu transplantacji serca w Poznaniu ...... 31 Maciej G£YDA, Przeszczepianie nerek .................. 35 Teresa DRYL-RYDZYÑSKA, Stacja dializ jako model do dyskusji nad rozwi¹zaniami systemowymi w ochronie zdrowia w Polsce ............... 49 Jacek SOBCZAK, Ramy prawne transplantacji ............... 67 Lech K. PAPRZYCKI, Nielegalny obrót komórkami, tkankami lub narz¹dami cz³owieka – wybrana problematyka kryminalizacji i penalizacji ............ 83 Teresa GARDOCKA, Zw³oki ludzkie w kontekœcie pobrania komórek, tkanek i narz¹dów w celach transplantacyjnych i nie tylko ................ 93 Joanna HABERKO, Kilka uwag o pobraniu tkanek, komórek i narz¹dów ex mortuo od cudzoziemców ........................ 101 Jêdrzej SKRZYPCZAK, Przeszczep mózgu a podmiotowoœæ prawna cz³owieka .... 111 Ks. Adam SIKORA, Transplantacja narz¹dów w perspektywie religijno-moralnej .... 121 Bartosz HORDECKI, Przedmiot w³asnoœci czy u¿ytkowania? Percepcja cia³a w kulturze europejskiej .......................... 129 El¿bieta JÊCZMIONKA, Zabiegi transplantacyjne – perspektywa biorców ...... 139 MISCELLANEA Ma³gorzata RAJCA, Ewa NOWOSIELSKA, Postêpowanie mediacyjne w ramach odpowiedzialnoœci zawodowej lekarzy ................. 145 Jolanta OR£OWSKA-HEITZMAN, Sprawozdanie okrêgowych rzeczników odpowiedzialnoœci zawodowej i Naczelnego Rzecznika Odpowiedzialnoœci Zawodowej za rok 2010 ... 155 Wojciech £¥CKI, Naczelny S¹d Lekarski – dane liczbowe za 2010 r. ....... 157 ORZECZNICTWO Jêdrzej SKRZYPCZAK, Przegl¹d orzecznictwa NSL z 2010 r........... 161 Jêdrzej SKRZYPCZAK, Postêpowanie w przedmiocie odpowiedzialnoœci zawodowej lekarzy w œwietle orzecznictwa S¹du Najwy¿szego (s¹du kasacyjnego) ......... 197 4 Spis treœci WM 3/2011 SPRAWY MIÊDZYNARODOWE Orzecznictwo Europejskiego Trybuna³u Praw Cz³owieka dotycz¹ce spraw medycznych wydane przeciwko Polsce w latach 2010–2011 (opracowanie Magdalena ZAMROCZYÑSKA) .............. 209 KONFERENCJE I SYMPOZJA .................. 249 RECENZJE ......................... 255 NOTY BIOGRAFICZNE ..................... 263 INFORMACJA DLA AUTORÓW ................. 265 Contents Editor’s Note ........................... 7 Marek WONIAK, Region of Wielkopolska – favourably disposed to transplantation .. 9 ARTICLES AND STUDIES Wojciech DYSZKIEWICZ, Lung transplantation ............... 11 Ewa SPEICHERT-M¥DRA, Krzysztof OLBROMSKI, Provision of haematopoietic cells in theory and in practice ..................... 17 Jacek WACHOWIAK, Transplantation of haematopoietic cells from unrelated donors in children and adolescents .................... 25 Marek JEMIELITY, Emergence of heart transplantation programme in Poznan .... 31 Maciej G£YDA, Renal transplantation .................. 35 Teresa DRYL-RYDZYÑSKA, Dialysis centre as a reference in discussion on system solutions for the Polish health care .................. 49 Jacek SOBCZAK, Legal framework for transplantation ............ 67 Lech K. PAPRZYCKI, Illegal trade in human cells, tissues or organs – criminalisation and penalisation: selected issues ................... 83 Teresa GARDOCKA, Human corpse in the context of cells, tissues and organs collection for transplantation and other purposes ................. 93 Joanna HABERKO, A few remarks on collection of cells, tissues, and organs ex mortuo from deceased aliens ....................... 101 Jêdrzej SKRZYPCZAK, Brain transplantation and legal subjectivity of a person ... 111 Ks. Adam SIKORA, Organ transplantation in the religious and moral context .... 121 Bartosz HORDECKI, A property or utility item? The perception of human body in the European culture ...................... 129 El¿bieta JÊCZMIONKA, Transplantation procedures – the recipients’ viewpoint .... 139 MISCELLANEA Ma³gorzata RAJCA, Ewa NOWOSIELSKA, Mediatorial proceedings within the scope of professional liability of physicians.................. 145 Jolanta OR£OWSKA-HEITZMAN, Report of the Regional Screeners for Professional Liability and the Supreme Screener for Professional Liability for the year 2010 . 155 Wojciech £¥CKI, Supreme Medical Court in facts and figures, 2010 ....... 157 JURIDICTION Jêdrzej SKRZYPCZAK, A review of the Supreme Medical Court’s jurisdiction for 2010 . 161 Jêdrzej SKRZYPCZAK, Professional liability proceedings concerning physicians in the light of the Supreme Court (of Appeal) jurisdiction ............ 197 6 Contents WM 3/2011 INTERNATIONAL AFFAIRS The European Court of Human Rights–areview of its jurisdiction (compiled by Magdalena ZAMROCZYÑSKA) .............. 209 CONFERENCES AND SYMPOSIA ................. 249 REVIEWS .......................... 255 BIOGRAPHICAL NOTES .................... 263 INSTRUCTION FOR THE AUTHORS ............... 265 Od Redakcji Trzeci numer czasopisma naukowego „Medyczna Wokanda”, wydawanego przez Na- czeln¹ Radê Lekarsk¹, poœwiêcony zosta³ niemal w ca³oœci problematyce transplanto- logicznej. Uznaliœmy, i¿ jest to obecnie na tyle istotna medycznie, prawnie i spo³ecznie kwestia, ¿e wymaga g³êbszej analizy, a tym samym udostêpnienia ³amów naszego pe- riodyku. Pretekstem do wyboru tego zagadnienia jako wiod¹cego w tym numerze, by³ program „Partnerstwo dla transplantacji”, realizowany w Wielkopolsce za spraw¹ Marsza³ka Województwa Wielkopolskiego pana Marka WoŸniaka. W pierwszej czêœci zamieszczaliœmy artyku³y autorstwa
Load more

Recommended publications
  • History of Lung Transplantation Akciğer Transplantasyonu Tarihçesi
    REVIEW History of Lung Transplantation Akciğer Transplantasyonu Tarihçesi Gül Dabak Unit of Pulmonology, Kartal Kosuyolu Yüksek Ihtisas Teaching Hospital for Cardiovascular Diseases and Surgery, İstanbul ABSTRACT ÖZET History of lung transplantation in the world dates back to the early 20 Dünyada akciğer transplantasyonu tarihçesi, deneysel çalışmala- th century, continues to the first clinical transplantation performed rın yapılmaya başlandığı 20. yüzyılın ilk yıllarından itibaren Ja- by James Hardy in the United States of America in 1963 and comes mes Hardy’ nin Amerika Birleşik Devletleri’nde 1963’te yaptığı to the present with increased frequency. Over 40.000 heart-lung ilk klinik transplantasyona uzanır ve hızlanarak günümüze gelir. and lung transplantations were carried out in the world up to 2011 yılına kadar dünyada 40,000’in üzerinde kalp-akciğer ve 2011. The number of transplant centers and patients is flourishing akciğer transplantasyonu yapılmıştır. Transplantasyon alanındaki in accordance with the increasing demand and success rate in that artan ihtiyaca ve başarılara paralel olarak transplant merkezleri arena. Lung transplantations that started in Turkey at Sureyyapasa ve hasta sayıları da giderek artmaktadır. Türkiye’de 2009 yılında Teaching Hospital for Pulmonary Diseases and Thoracic Surgery Süreyyapaşa Göğüs Hastalıkları ve Cerrahisi Eğitim ve Araştırma in 2009 are being performed at two centers actively to date. This Hastanesi’ nde başlayan akciğer transplantasyonları günümüzde review covers a general outlook on lung transplantations both in iki merkezde aktif olarak yapılmaktadır. Bu derlemede, ülkemiz- the world and in Turkey with details of the first successful lung deki ilk başarılı akciğer transplantasyonu detaylandırılarak dün- transplantation in our country. yada ve ülkemizdeki akciğer transplantasyonu tarihçesi gözden Keywords: Lung transplantation, heart-lung transplantation, his- geçirilmektedir.
    [Show full text]
  • AI Watch Artificial Intelligence in Medicine and Healthcare: Applications, Availability and Societal Impact
    JRC SCIENCE FOR POLICY REPORT AI Watch Artificial Intelligence in Medicine and Healthcare: applications, availability and societal impact EUR 30197 EN This publication is a Science for Policy report by the Joint Research Centre (JRC), the European Commission’s science and knowledge service. It aims to provide evidence-based scientific support to the European policymaking process. The scientific output expressed does not imply a policy position of the European Commission. Neither the European Commission nor any person acting on behalf of the Commission is responsible for the use that might be made of this publication. For information on the methodology and quality underlying the data used in this publication for which the source is neither Eurostat nor other Commission services, users should contact the referenced source. The designations employed and the presentation of material on the maps do not imply the expression of any opinion whatsoever on the part of the European Union concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Contact information Email: [email protected] EU Science Hub https://ec.europa.eu/jrc JRC120214 EUR 30197 EN PDF ISBN 978-92-76-18454-6 ISSN 1831-9424 doi:10.2760/047666 Luxembourg: Publications Office of the European Union, 2020. © European Union, 2020 The reuse policy of the European Commission is implemented by the Commission Decision 2011/833/EU of 12 December 2011 on the reuse of Commission documents (OJ L 330, 14.12.2011, p. 39). Except otherwise noted, the reuse of this document is authorised under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence (https://creativecommons.org/licenses/by/4.0/).
    [Show full text]
  • What Are You?
    Human Being or Human Brain? Animalism and the Problem of Thinking Brains Ida Anderalm Master’s Thesis in Philosophy, 30 credits Spring 2016 Supervisor: Pär Sundström Department of Historical, Philosophical and Religious Studies Abstract Animalismens huvudargument säger att du är det tänkande objektet som sitter i din stol, och enligt animalisterna själva innebär detta att du är identisk med ett mänskligt djur. Argumentet är dock problematiskt då det inte tycks utesluta eventuella tänkande delar hos det mänskliga djuret, som till exempel dess hjärna. Detta beror på att hjärnor också kan beskrivas som tänkande, samt att även de befinner sig inom det spatiella område som upptas av det mänskliga djuret. I den här uppsatsen argumenterar jag för att tänkande hjärnor är ett problem för animalismen och att tesen att vi är identiska med hjärnor är ett verkligt hot mot den animalistiska teorin om personlig identitet. Olika argument som lagts fram mot tesen att vi är hjärnor avhandlas, som till exempel att hjärnor inte existerar och att hjärnor inte tänker. Jag diskuterar även två argument som tidigare använts för att visa att vi är personer snarare än mänskliga djur (the Transplant Intuition och the Remnant Person Problem), men i det här sammanhanget bedöms de utifrån deras förmåga att stödja hjärnteorin. Contents 1. Introduction ............................................................................................................................ 1 1.1 Personal Identity ..............................................................................................................
    [Show full text]
  • To Clinical Xenogeneic Heart Transplantation. Presented at the 15Th Biannual IXA Meeting, Munich, October 11, 2019
    Received: 23 June 2020 | Accepted: 30 July 2020 DOI: 10.1111/xen.12637 REVIEW ARTICLE On the way (my way) to clinical xenogeneic heart transplantation. Presented at the 15th biannual IXA meeting, Munich, October 11, 2019 Bruno Reichart1 | Matthias Längin2 1Transregional Collaborative Research Center 127, Walter Brendel Centre of Experimental Medicine, LMU Munich, Munich, Germany 2Department of Anaesthesiology, University Hospital, LMU Munich, Munich, Germany Correspondence: Bruno Reichart, Walter Brendel Centre of Experimental Medicine, LMU Munich, Marchioninistraße 27, 81377 Munich, Germany. Email: [email protected] 1 | PRECLINICAL AND At the Ludwig-Maximilians University in Munich, Walter Brendel CLINICAL CONCORDANT HEART (1922-1989) became Head of the Department of Experimental XENOTRANSPLANTATION Surgery (now the “Walter Brendel Center for Experimental Medicine”). During most of the 1960s till the first half of the 1980s, The first heart replacement in humans was a xenograft. On January xenotransplantation remained one of his main interests—and that 23, 1964, James Hardy (1918-2003) from Mississippi, USA, re- of his consultant and chief investigator Claus Hammer (1940-2015). moved the heart of a dying 68-year-old adult and replaced it with The latter characterized preformed natural antibodies (PNABs)4 in the organ of a small chimpanzee. After 90 minutes, the transplant sera of 48 species from seven zoological orders and investigated stopped beating, because it was of course too small.1 Hardy was more than 8300 combinations of serum samples and antigens of heavily criticized by both the public and his medical peers—partly 111 individuals. Among others, his key finding was that PNABs were unfair since he and his team had prepared the intervention care- absent or low between the species within a zoological family (con- fully over years; he should, however, have selected a better first cordant systems) such as domestic dogs, foxes and dingos; domestic recipient.
    [Show full text]
  • Transplantation and Stem Cell Research in Neurosciences: Where Does India Stand?
    Review Article Transplantation and stem cell research in neurosciences: Where does India stand? Prakash N. Tandon Emeritus Professor, Neurosurgery, All India Institute of Medical Sciences, New Delhi and President, National Brain Research Centre, Manesar, Haryana, India Abstract The nearly absent ability of the neurons to regenerate or multiply has prompted neuroscientists to search for the mean to replace damaged or dead cells. The failed attempts using adult tissue, initiated nearly a century ago, ultimately brought rays of hope when developing fetal neurons were used for transplantation in 1970s. The Address for correspondence: initial excitement was tempered by limited success and ethical issues. But these efforts Dr. Prakash N. Tandon, unequivocally established the feasibility of successful neural transplantation provided National Brain Research Centre appropriate tissue was available. The ability to derive embryonic stem cells with (NBRC), Nainwal More, their totipotent potential by Thomson in 1998 rekindled the interest in their use for Manesar - 122 050, Haryana, India. replacement therapy for damaged brain tissue. The present review surveys the current E-mail: [email protected] status of this promising field of stem cell research especially in respect to their therapeutic potentials for purposes of neural transplantation. A brief account is provided of the ongoing Indian efforts in this direction. PMID: *** DOI: 10.4103/0028-3886.59464 Key words: Adult neural stem cells, embryonic stem cells, neural transplantation Historical Background that for once the neurosurgeons jumped straight from the “rat-to-man” without even waiting for the results of the While attempts at neural transplantation for repair of studies in higher primates.
    [Show full text]
  • "Xenotransplantation". In: Encyclopedia of Life Sciences (ELS)
    Xenotransplantation Introductory article Article Contents David KC Cooper, University of Pittsburgh, Pittsburgh, Pennsylvania, USA . History of Xenotransplantation Mohamed Ezzelarab, University of Pittsburgh, Pittsburgh, Pennsylvania, USA . Need for Xenotransplantation Hidetaka Hara, University of Pittsburgh, Pittsburgh, Pennsylvania, USA . Problems Associated with Rejection of Pig Organs Based in part on the previous version of this Encyclopedia of Life Sciences . Xenotransplantation of Cells (ELS) article, Xenotransplantation by Robert P Lanza and David KC . Problems Associated with Potential Infection Cooper. The Function of Pig Organs in Humans . Other Issues The transplantation of organs and tissues across species boundaries is called xenotransplantation. The most likely source of animal organs and cells for doi: 10.1002/9780470015902.a0001249.pub2 transplantation into humans is the pig. Pigs, therefore, have been genetically engineered to provide their tissues with some protection against the human immune response. However, further immunological barriers need to be overcome. Many questions remain regarding the adequate function of pig organs in humans. The safety of xenotransplantation also remains of some concern. Is there a risk of the transfer of a pig infectious microorganism into the community? Present evidence is that this potential risk is low. This potential, however, has legal and regulatory implications. History of Xenotransplantation went on to transplant occasional chimpanzee or baboon livers in critically ill patients. James Hardy and Leonard The concept of blending parts derived from different spe- Bailey carried out single chimpanzee and baboon heart cies goes back centuries. Centaurs, mermaids and other transplants in patients in 1964 and 1984, respectively. All of creatures from classical mythology come vividly to mind.
    [Show full text]
  • Lung T Ransplantation
    Lung t ransplantation 9 Jonathan E Spahr 1 and Keith C Meyer 2 1 Children ’ s Hospital of Pittsburgh and the University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA 2 University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA Allotransplantation of the human lung was fi rst per- prevent them have extended survival and provided formed in 1963 by Dr James Hardy at the University most recipients with an improved quality of life after of Mississippi. It did not become successful enough lung transplantation. to achieve acceptance as a treatment for end - stage This chapter focuses on the three main aspects of lung disease (ESLD) until the mid - 1980s to the early optimizing the outcome of lung transplantation: fi rst, 1990s when improved surgical techniques, advances patient selection and appropriate timing and criteria in organ preservation, and the development and clini- for lung transplantation is reviewed; the focus then cal implementation of novel immunosuppressive turns to the technical aspects of the procedure; fi nally, drugs allowed long - term survival of lung allograft attention focuses on perioperative and postoperative recipients. Lung transplantation has evolved consid- complications and strategies to prevent or treat such erably over the past two decades and is now a defi ni- complications. tive treatment for ESLDs that do not respond to other therapeutic interventions. As lung transplantation has become accepted as a life - prolonging therapy for Selection of p atients for ESLD and performed at various centers world - wide, l ung t ransplantation many complications have been identifi ed, and methods Indications and c ontraindications for monitoring and treating those complications have arisen.
    [Show full text]
  • Mechanisms and Use of Neural Transplants for Brain Repair
    Dunnett & Björklund, FNT-IV, chapter 1 page | 1 Mechanisms and Use of Neural Transplants for Brain Repair Stephen B Dunnett 1*, Anders Björklund 2 1 School of Biosciences, Cardiff University, Museum Avenue, Cardiff CF10 3AX, UK. 2 Wallenberg Neuroscience Center, Lund University, BMC A11, 22184,Lund, Sweden. * Corresponding author. Tel: +44 2920 875188, Fax: +44 2920 876749, email address: [email protected]. Abstract Under appropriate conditions, neural tissues transplanted into the adult mammalian brain can survive, integrate and function so as to influence the behaviour of the host, opening the prospect of repairing neuronal damage and alleviating symptoms associated with neuronal injury or neurodegenerative disease. Alternative mechanisms of action have been postulated : non-specific effects of surgery; neurotrophic and neuroprotective influences on disease progression and host plasticity; diffuse or locally-regulated pharmacological delivery of deficient neurochemcials, neurotransmitters or neurohormones; restitution of the neuronal and glial environment necessary for proper host neuronal support and processing; promoting local and long distance host and graft axon growth; formation of reciprocal connections and reconstruction of local circuits within the host brain; up to full integration and reconstruction of fully functional host neuronal networks. Analysis of neural transplants in a broad range of anatomical systems and disease models, on simple and complex classes of behavioural function and information processing, have indicated
    [Show full text]
  • History of Heart Transplantation: a Hard and Glorious Journey
    SPECIAL ARTICLE - HISTORIC Braz J Cardiovasc Surg 2017;32(5):423-7 History of Heart Transplantation: a Hard and Glorious Journey Noedir A. G. Stolf1, MD, PhD DOI: 10.21470/1678-9741-2017-0508 INTRODUCTION contractions were seen. Afterward contractions appeared and about an hour after the operation, effective contractions of This year we celebrate 50 years of the first interhuman heart the ventricles began. The transplanted heart beat at the rate of transplantation. So, I believe that it is interesting to review the 88 per minute, while the rate of the normal heart was 100 per most important steps of this glorious journey. minute. A little later tracing was taken. Owing to the fact that Heart transplantation first performed in the course of the operation was made without aseptic technique, coagulation experiments of other nature in the beginning of 20th century, occurred in the cavities of the heart after about two hours, and seen as a speculation for the future in the middle of the same the experiment was interrupted”. century, is now widely accepted by medical and lay communities Although the exact details of experiments were not known as a valuable therapeutic procedure. the most probable arrangement of anastomosis are shown in This history can be divided into an experimental and a Figure 1 adaptation in a book by Najarian and Simmons[2]. The clinical heart transplantation periods, with the first one in problem with this model is that arterial inflow is in the atrium heterotopic non-auxiliary, heterotopic auxiliary and orthotopic and aortic outflow is under venous pressure, in other words, transplantations.
    [Show full text]
  • Fetal Stem Cell Transplantation : Past, Present, and Future
    Title Fetal stem cell transplantation : Past, present, and future Author(s) Ishii, Tetsuya World Journal of Stem Cells, 6(4), 404-420 Citation https://doi.org/10.4252/wjsc.v6.i4.404 Issue Date 2014-09-26 Doc URL http://hdl.handle.net/2115/56999 Rights(URL) http://creativecommons.org/licenses/by/4.0/ Type article File Information 404.pdf Instructions for use Hokkaido University Collection of Scholarly and Academic Papers : HUSCAP Submit a Manuscript: http://www.wjgnet.com/esps/ World J Stem Cells 2014 September 26; 6(4): 404-420 Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx ISSN 1948-0210 (online) DOI: 10.4252/wjsc.v6.i4.404 © 2014 Baishideng Publishing Group Inc. All rights reserved. REVIEW Fetal stem cell transplantation: Past, present, and future Tetsuya Ishii, Koji Eto Tetsuya Ishii, Office of Health and Safety, Hokkaido University, Kita-ku, Sapporo 060-0808, Hokkaido, Japan Core tip: Based on the history of fetal stem cell trans- Koji Eto, Center for iPS Cell Research and Application, Kyoto plantation since 1928, this article discusses strategies University, Shogoin Yoshida, Sakyo-ku, Kyoto 606-8507, Japan for transplantation, with a focus on donor cells, cell Author contributions: Ishii T investigated the reports on clini- processing, and the therapeutic cell niche, in addition cal trials and wrote the manuscript; Eto K assessed the analysis to ethical issues associated with fetal origin. We de- and revised the manuscript. scribed the stream line to current clinical trials using Supported by JSPS KAKENHI, No. 26460586(TI) fetal and embryonic stem cells based on Clinical. Trials.
    [Show full text]
  • Transplant Updates
    Heart Transplantation A Half Century of Progress April 6, 2019 David D’Alessandro, M.D. Surgical Director, Cardiac Transplantation and Mechanical Circulatory Support Disclosures • None 2 Heart Transplantation • How did we get there? • How far have we come? • Where are we going? The danger of touching the heart "Surgery of the heart has probably reached the limits set by Nature to all surgery. No method, no new discovery, can overcome the natural difficulties that attend a wound of the heart." Stephen Paget, 1896 Alexis Carrel • published his technique for the vascular anastomosis in 1902 • 1905 reported heterotopic kidney and heart transplantation in dogs • Nobel Prize in Physiology 1912 History of Cardiac History Evolution of CPB Early Challenges in Cardiac Surgery 1920s - 1950s • Multiple failed attempts at operative treatment of rheumatic mitral stenosis • Poor visualization during ASD repairs Tubbs dilator Heart Lung Machine John Gibbon 1953 Cecilia Brevolek: May 6th as the first successful truly open-heart operation performed with the use of a heart-lung machine. Norman Shumway Surg Forum 1960;11:18. James Hardy • First human cardiac transplant was a chimpanzee xenograft performed at the University of Mississippi in 1964. Operative Permit Public ridicule “…not only immoral, but amoral”. Richard Lower • 1966 Lower performed “a reverse Hardy” • Passed up an opportunity to perform a human to human transplant in 1966 due to over cautious concern about secondary incompatibility Christiaan Barnard Louis Washkansky (December 3, 1967) “My moment of truth – the moment when the enormity of it all really hit me – was just after I had taken out Washkansky’s heart.
    [Show full text]
  • Introduction
    Notes Introduction 1. Telephone interview with Danelle DiCiantis, conducted by Annie Evans, November 19, 2000; Laura Rothenberg, “My So-Called Lungs,” in Sayantani DasGupta and Marsha Hurst (eds.), Stories of Illness and Healing; Women Write Their Bodies (Kent, OH: Kent State University Press, 2007), 44. The number of lung trans- plants in 1990 cited in “Report of the ATS Workshop on Lung Transplantation,” American Review of Respiratory Disease 147 (1993): 772–776; 2010 waiting list data cited in “Waiting List Additions 2000-2010 U.S.,” OPTN/UNOS 2011 Data Spring Regional Meetings, http://www.unos.org/docs/DataSlides_Spring_2011.pdf, accessed June 8, 2011. 2. For a critique of the assumptions and practices of modern medicine, see John D. Engel et al., Narrative in Health Care; Healing Patients, Practitioners, Profession, and Community (Oxford and New York: Radcliffe Publishing, 2008), 25–31; and Arthur W. Frank, The Wounded Storyteller: Body, Illness, and Ethics (University of Chicago Press, 1995), 54–56, 81–85, and 172. 3. These cost estimates were for first-year billed charges for a transplant; costs for immunosuppression drugs and other treatment continued well beyond the first year. Millman Research Report, “2008 U.S. Organ and Tissue Transplant Cost Estimates and Discussion,” http://publications.milliman.com/research/health-rr/pdfs/2008 -us-organ-tisse-RR4-1-08.pdf, accessed June 8, 2011. 4. Rhonda Bodfield, “Appeal for Transplant Patient,” Arizona Daily Star , December 17, 2010; Jane E. Allen, “Arizona Budget Cuts Put Some Organ Transplants Out of Reach,” ABC News/Health, November 18, 2010, http://abcnews.go.com/Health/Health_Care /medicaid-cuts-make-organ-transplants-unaffordable/story?id=12177059, accessed June 8, 2011.
    [Show full text]